Samrat Pharmachem Ltd vs Zydus Lifesciences Limited
A side-by-side comparison of Samrat Pharmachem Ltd (SAMRATPH) and Zydus Lifesciences Limited (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Zydus Lifesciences Limited leads SAMRATPH vs ZYDUSLIFE on 9 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation31
- Profitability04
- Growth01
- Size & financial health13
Valuation
SAMRATPH takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
ZYDUSLIFE takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
ZYDUSLIFE takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
ZYDUSLIFE takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + []
- − ["Company has a low return on equity of 3.0% over last 3 years.", "Company reported a net loss of ₹3 Cr in its latest financial year."]
- + ["Company has delivered good profit growth of 18.6% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 20.9%"]
- − []
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.